Download PDF
Exp Clin Endocrinol Diabetes 2021; 129(06): 438-442
DOI: 10.1055/a-0942-1789
Article

Healing and Mortality Rates Following Toe Amputation in Type 2 Diabetes Mellitus

Ian Mario Vassallo
1   Department of Health, Malta
,
Alfred Gatt
2   Faculty of Health Sciences, University of Malta, Msida, Malta
,
Kevin Cassar
1   Department of Health, Malta
3   Faculty of Medicine and Surgery, University of Malta, Msida, Malta
,
Nikolaos Papanas
4   Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, University Hospital of Alexandroupolis, Greece
,
Cynthia Formosa
2   Faculty of Health Sciences, University of Malta, Msida, Malta
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Background and Aim This single-centre study aimed to determine healing, re-ulceration, re-amputation and mortality rates at one year after toe amputations in patients with type 2 diabetes (T2DM).

Patients and Methods Eighty-one participants with T2DM admitted for toe amputation were included. Patient characteristics, peripheral circulation and neuropathy status were recorded. Subjects were then followed every 3 months post-amputation for a year.

Results Overall, 59.3% of participants underwent further surgery (n=31 to revise the original amputation site and n=17 to amputate a new site). During 12 months, 45.7% of participants presented with a new ulcer at a different site. Mortality was 7.4%. In 12.4% of participants, the amputation site remained incompletely healed. Only 20.9% had no complications in 12 months. At 12 months, 80.2% of study cohort had a completely healed amputation site.

ConclusionIn conclusion, this study highlighted high re-intervention, re-amputation and new ulceration rates. Strategies to improves these outcomes in such high-risk patients are warranted.

Key words

diabetic foot - mortality - foot morbidity - amputations - healing


Publication History

Received: 24 March 2019
Received: 13 May 2019

Accepted: 27 May 2019

Article published online:
17 June 2019

© 2019. Thieme. All rights reserved.

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Boulton AJM. The diabetic foot. Medicine 2014; 43: 33-37
    CrossrefPubMedGoogle Scholar
  • 2 Wong K, Nather A, Lim J et al. Clinical outcomes of diabetic foot patients following ray amputation. Sixth International Symposium on the Diabetic Foot. Noordwijkerhout 2011
    PubMed
  • 3 Carabott M, Formosa C, Mizzi A et al. Thermographic characteristics of the diabetic foot with peripheral arterial disease using the angiosome concept. Exp Clin Endocrinol Diabetes 2019 [Epub ahead of print]
    PubMed
  • 4 Formosa C, Gatt A, Chockalingham N. A critical evaluation of existing diabetic foot screening guidelines. Rev Diabet Stud 2016; 13: 158-186
    CrossrefPubMedGoogle Scholar
  • 5 Norgren L, Hiatt WR, Dormandy JA. et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45 Suppl S S5-S67
    CrossrefPubMedGoogle Scholar
  • 6 Orchard T, Strandness D. Assessment of Peripheral Vascular Disease in Diabetes: Report and Recommendations of an International Workshop Sponsored by the American Heart Association and the American Diabetes Association. Diabetes Care 1993; 16: 1199-1209
    CrossrefPubMedGoogle Scholar
  • 7 Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev 2004; 20 (Suppl. 01) S90-S95
    CrossrefPubMedGoogle Scholar
  • 8 Borkosky SL, Roukis TS. Incidence of re-amputation following partial first ray amputation associated with diabetes mellitus and peripheral sensory neuropathy. Diabetic Foot and Ankle 2012; 3: 12169
    CrossrefPubMedGoogle Scholar
  • 9 Uzzaman MM, Jukakau S, Kambal A. et al. Assessing the long-term outcomes of minor lower limb amputations: A 5-year study. Angiology 2011; 62: 365-371
    CrossrefPubMedGoogle Scholar
  • 10 Jindeel A, Narahara KA. Non-traumatic amputation: Incidence and cost analysis. The Int J Lower Extrem Wounds 2012; 11: 177-179
    CrossrefPubMedGoogle Scholar
  • 11 Faglia E, Clerici G, Frykberg R. et al. Outcomes of Chopart amputation in a tertiary referral diabetic foot clinic: Data from a consecutive series of 83 hospitalized patients. J Foot Ankle Surg 2016; 230-234
    CrossrefPubMedGoogle Scholar
  • 12 Quebedeaux TL, Lavery LA, Lavery DC. The development of foot deformities and ulcers after great toe amputation in diabetes. Diabetes Care 1996; 19: 165-167
    CrossrefPubMedGoogle Scholar
  • 13 Gershater MA, Londahl M, Nyberg P. et al. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: A cohort study. Diabetologia 2009; 52: 398-407
    CrossrefPubMedGoogle Scholar
  • 14 Wilbek TE, Jansen RB, Jørgensen B. et al. Risk factors for premature death in diabetes patients who undergo amputations below ankle level. Exp Clin Endocrinol Diabetes 2018; 126: 61-65
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Wilbek TE, Jansen RB, Jørgensen B. et al. The diabetic foot in a multidisciplinary team setting. Number of amputations below ankle level and mortality. Exp Clin Endocrinol Diabetes 2016; 124: 535-540
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Morbach S, Müller E, Reike H. et al. Diabetic foot syndrome. Exp Clin Endocrinol Diabetes 2014; 122: 416-424
    Article in Thieme ConnectPubMedGoogle Scholar